Alexander Scheer has extensive experience in the biotechnology and pharmaceutical sectors, holding various leadership positions such as Chief Executive Officer at CasInvent Pharma and Chief Scientific Officer at Aelin Therapeutics and ERYTECH Pharma. Previous roles include Head of Molecular Screening and Cellular Pharmacology at Serono International S.A. and Project Leader for Neglected Diseases at Merck Serono, focusing on discovering new therapies for diseases like Malaria in collaboration with WHO/TDR. Alexander's academic background includes a PhD from DKFZ German Cancer Research Center and multiple degrees from the University of Lausanne in Molecular Pharmacology and Cellular Biology. Current engagements involve consulting as President & Founder of AS Life Science Consulting and serving as Chief Scientific Officer at BioLizard.
This person is not in the org chart
This person is not in any teams
This person is not in any offices